Shareholders sue Amgen over anti-anemia drugs

Amgen Inc. is the subject of a class-action suit announced late yesterday by San Diego-based law firm Lerach Coughlin Stoia Geller Rudman & Robbins LLP. “We believe the allegations have no merit,” Amgen spokesman David Polk told Providence Business News in an e-mail this morning. The lawsuit, in U.S. District Court for the Central District…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -